Sep 14, 2020 / 07:00PM GMT
David Ryan Lewis - Morgan Stanley, Research Division - MD
Good day, everyone, this is David Lewis, Medical Device Analyst at Morgan Stanley. Thanks for joining us here as we progress into the afternoon on day 1 of the Morgan Stanley Healthcare Conference 2020. It's my pleasure to have with us here Nevro and both their President and CEO; and Rod MacLeod, their CFO, this morning.
I think Keith's going to dispense with any preamble, we're going to jump right into Q&A. As I always mentioned that before I start, please go to the Morgan Stanley research disclosure website and see my research disclosures and other fun facts about me.
Questions and Answers:
David Ryan Lewis - Morgan Stanley, Research Division - MDBut look, we always appreciate, Keith, when a company comes to our conference, it comes out with new -- fresh news announcements, so we'll start there. So manufacturing, I mean, this has been a -- since the IPO of Nevro, this is a question I've asked the prior CFO every single year. When do you take more control of your long-term
Trustpilot
